Clinical trials for precision oncology using next-generation sequencing

Personalized Medicine
Richard Simon, Eric C Polley

Abstract

The demonstrated genomic heterogeneity of human cancers is having major impacts on the development and evaluation of cancer therapeutics and molecular diagnostics. Many new cancer drugs target somatic alterations in tumors and are being developed with companion diagnostics. Oncology drug development and practice are likely to become increasingly stratified and utilize the enrichment Phase III trial paradigm. Although this paradigm includes an increasing number of successes, single-agent molecularly targeted treatment of metastatic disease will generally provide limited patient benefit. More substantial gains will require better understanding of crosstalk among signaling pathways, ability to combine drugs and use of drugs at initial diagnosis. Early phase discovery clinical trials in which patients will have genome-wide tumor characterization at diagnosis and at critical retreatment points will provide data sets for learning how to effectively match therapeutics to genomic alterations. However, moving tumor genomics to clinical oncology entails many practical challenges. We review some of these challenges and the clinical studies that are being undertaken to translate genomics to clinical oncology.

References

Nov 20, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L Pusztai, K R Hess
Apr 7, 2007·Contemporary Clinical Trials·Cheryl L Jones, Eric Holmgren
Apr 26, 2007·Clinical Trials : Journal of the Society for Clinical Trials·Richard L Schilsky
Jun 29, 2007·Journal of the National Cancer Institute·Wenyu JiangRichard Simon
Jun 24, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Marc Ladanyi, William Pao
Apr 11, 2009·Nature·Michael R StrattonP Andrew Futreal
May 15, 2009·Clinical Pharmacology and Therapeutics·A D BarkerL J Esserman
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel D Von HoffRobert Penny
Dec 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward L Korn, Boris Freidlin
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Nov 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Howard I ScherRichard Simon
Nov 11, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L V SequistD Dias-Santagata
Nov 16, 2011·Nature Reviews. Clinical Oncology·Miriam MartiniAlberto Bardelli
Dec 3, 2011·Science Translational Medicine·Sameek RoychowdhuryArul M Chinnaiyan
Jan 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ben TranLillian L Siu
May 16, 2012·Cancer Discovery·Edward S KimWaun K Hong
Jun 21, 2012·Statistics in Medicine·Richard Simon
Jul 11, 2012·Nature Reviews. Clinical Oncology·Frédérique NowakFabien Calvo
Aug 8, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Boris FreidlinEdward L Korn
Aug 28, 2012·Science·Gopa IyerDavid B Solit
Sep 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Apostolia-Maria TsimberidouRazelle Kurzrock
Nov 10, 2012·Nature Biotechnology·Amy S GargisIra M Lubin
Nov 20, 2012·Targeted Oncology·Christophe Le TourneauXavier Paoletti

❮ Previous
Next ❯

Citations

Feb 26, 2016·PloS One·Miranta AntoniouRuwanthi Kolamunnage-Dona
Sep 7, 2017·Journal of Biopharmaceutical Statistics·Richard Simon
Sep 1, 2016·Therapeutic Innovation & Regulatory Science·Sheikh Usman IqbalL Clark Paramore
Jan 27, 2017·Journal of Personalized Medicine·Miranta AntoniouAndrea L Jorgensen
Sep 26, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P C BarataP Grivas

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
genotyping
amplicon sequencing
RNA-seq

Software Mentioned

MI
WINTHER
ONCOSEQ
MOSCATO
My Genome

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Richard Simon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Howard I ScherRichard Simon
Journal of the National Cancer Institute
Shivaani KummarJames H Doroshow
© 2022 Meta ULC. All rights reserved